Tocagen Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Tocagen Inc
TickerFBRX
CIK #0001419041
CUSIP34962G109
SectorLife Sciences - Pharmaceutical Preparations
Address3030 Bunker Hill Street, Suite 230, San Diego, CA 92109
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Forte Biosciences Inc 2023-08-09 25.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Tocagen Inc 2016-12-06 10.9 M Exemption: 506(b) · Remaining: $2,104,250 · Duration: More than one year · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001419041] 10-K
[0001419041] 10-Q
[0001419041] 3
[0001419041] 4
[0001419041] 8-K
[0001419041] D
[0001419041] SC 13D
[0001419041] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC Forte Biosciences Inc [2026-06-08] 0.0
MPM Bioimpact LLC Forte Biosciences Inc [2026-05-15] 0.0
Adage Capital Management LP Forte Biosciences Inc [2026-05-13] 0.0
Point72 Asset Management LP Forte Biosciences Inc [2026-01-20] 0.0
Affinity Asset Advisors LLC Forte Biosciences Inc [2025-12-23] 0.0
Federated Hermes Inc Forte Biosciences Inc [2025-07-08] 0.0
Janus Henderson Group PLC Forte Biosciences Inc [2025-02-14] 0.0
OrbiMed Advisors LLC Forte Biosciences Inc [2025-02-14] 0.0
Ikarian Capital LLC Forte Biosciences Inc [2025-02-14] 0.0
Boothbay Fund Management LLC Forte Biosciences Inc [2025-02-13] 0.0
Oliveira Steven Michael Forte Biosciences Inc [2025-01-10] 0.0
Tybourne Capital Management HK Ltd Forte Biosciences Inc [2024-02-14] 0.99
Alger Associates Inc Forte Biosciences Inc [2023-09-12] 5.1
Perceptive Advisors LLC Forte Biosciences Inc [2023-09-08] 9.9
Camac Fund LP Forte Biosciences Inc [2023-08-23] 4.3
Farallon Capital Partners LP Forte Biosciences Inc [2023-08-10] 1.7
Biotechnology Value Fund L P Forte Biosciences Inc [2023-08-10] 4.4
JEC II Associates LLC Forte Biosciences Inc [2023-04-10] 5.43
ATG Fund II LLC Forte Biosciences Inc [2022-08-04] 9.9
Camac Fund LP Forte Biosciences Inc [2022-08-01] 7.5
BlackRock Inc Forte Biosciences Inc [2022-07-08] 1.5
Funicular Fund LP Forte Biosciences Inc [2022-07-05] 7.5
BML Investment Partners LP Forte Biosciences Inc [2022-05-24] 8.94
BML Investment Partners LP Forte Biosciences Inc [2022-05-04] 6.0
Morgan Stanley Forte Biosciences Inc [2022-02-11] 7.5
BlackRock Inc Forte Biosciences Inc [2022-02-04] 5.5
Logos Global Management LP Forte Biosciences Inc [2021-09-13] 0.0
Point72 Asset Management LP Forte Biosciences Inc [2021-05-18] 5.2
Perceptive Advisors LLC Forte Biosciences Inc [2021-03-22] 5.2
OrbiMed Advisors LLC Forte Biosciences Inc [2021-02-12] 4.74
Franklin Resources Inc Forte Biosciences Inc [2021-02-01] 8.2
Oliveira Steven Michael Forte Biosciences Inc [2020-09-01] 2.01
ArrowMark Colorado Holdings LLC Forte Biosciences Inc [2020-07-10] 27.19
Wagner Paul A Forte Biosciences Inc [2020-06-25] 21.04
Biotechnology Value Fund L P Forte Biosciences Inc [2020-06-25] 5.6
Oliveira Steven Michael Tocagen Inc [2020-02-28] 11.4
BlackRock Inc Tocagen Inc [2018-02-01] 5.4
EcoR1 Capital LLC Tocagen Inc [2017-05-10] 7.6
Foresite Capital Fund III LP Tocagen Inc [2017-04-25] 4.6
Biotechnology Value Fund L P Tocagen Inc [2017-04-21] 4.6
Form 3/4/5 Filer 2011 - 2026
Tocagen Inc
Riley Antony A
Wagner Paul A
Brun Scott C
Doberstein Stephen K
Kapoor Shivpreet Singh
Gryska David W
Vincent Richard G
Kornfeld Steven
Finck Barbara K
Williams Donald Allen
Eichenfield Lawrence
Chen Hubert C
Walker Patricia S
Darcy Thomas E
Oliveira Steven Michael
Gruber Harry E
Parkinson David Ross
Jolly Douglas
Foletta Mark G
Kabbinavar Fairooz
Duvall Martin J
Kunkel Lori Anne
Berger Franklin M
Hasnain Faheem
Schimmel Paul
Das Asha
Berman Dennis N
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Wagner Paul A
Restricted Stock Units · derivative
2026-01-12 Grant 180,000 $0.00
Riley Antony A
Stock Option (right to buy) · derivative
2026-01-12 Grant 90,000 $0.00
Riley Antony A
Restricted Stock Units · derivative
2026-01-12 Grant 60,000 $0.00
Wagner Paul A
Stock Option (right to buy) · derivative
2026-01-12 Grant 270,000 $0.00
Riley Antony A
Restricted Stock Units · derivative
2026-01-01 Option exercise 375 $0.00
Riley Antony A
Common Stock
2026-01-01 Tax withheld 154 $27.27 4,200
Wagner Paul A
Common Stock
2026-01-01 Option exercise 1,250 $0.00
Wagner Paul A
Common Stock
2026-01-01 Tax withheld 164 $27.27 4,472
Riley Antony A
Common Stock
2026-01-01 Option exercise 375 $0.00
Wagner Paul A
Restricted Stock Units · derivative
2026-01-01 Option exercise 1,250 $0.00
Riley Antony A
Common Stock
2025-12-30 Buy 9,680 $26.33 254,874
Riley Antony A
Common Stock
2025-10-01 Tax withheld 134 $14.52 1,946
Riley Antony A
Common Stock
2025-10-01 Option exercise 375 $0.00
Wagner Paul A
Common Stock
2025-10-01 Tax withheld 98 $14.52 1,423
Wagner Paul A
Common Stock
2025-10-01 Option exercise 1,250 $0.00
Riley Antony A
Restricted Stock Units · derivative
2025-10-01 Option exercise 375 $0.00
Wagner Paul A
Restricted Stock Units · derivative
2025-10-01 Option exercise 1,250 $0.00
Riley Antony A
Common Stock
2025-07-01 Option exercise 375 $0.00
Riley Antony A
Common Stock
2025-07-01 Tax withheld 134 $12.44 1,667
Wagner Paul A
Common Stock
2025-07-01 Tax withheld 98 $12.44 1,219
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 69 13,646,360
2025-12-31 59 11,545,305
2025-09-30 42 10,343,866
2025-06-30 35 9,819,013
2025-03-31 30 5,034,503
2024-12-31 27 4,275,837
2024-09-30 25 736,634
2024-06-30 35 19,071,746
2024-03-31 34 19,051,776
2023-12-31 36 18,876,299
2023-09-30 33 16,729,559
2023-06-30 32 3,473,604
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com